EXPRESS INC (EXPR) Fundamental Analysis & Valuation

NYSE:EXPR • US30219E2028

Current stock price

2.29 USD
+0.06 (+2.69%)
Last:

This EXPR fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. EXPR Profitability Analysis

1.1 Basic Checks

  • In the past year EXPR has reported negative net income.
  • EXPR had a negative operating cash flow in the past year.
  • The reported net income has been mixed in the past 5 years: EXPR reported negative net income in multiple years.
  • The reported operating cash flow has been mixed in the past 5 years: EXPR reported negative operating cash flow in multiple years.
EXPR Yearly Net Income VS EBIT VS OCF VS FCFEXPR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 200M -200M -400M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 12.19%, EXPR belongs to the top of the industry, outperforming 88.28% of the companies in the same industry.
  • Looking at the Return On Equity, with a value of 120.91%, EXPR belongs to the top of the industry, outperforming 97.66% of the companies in the same industry.
Industry RankSector Rank
ROA 12.19%
ROE 120.91%
ROIC N/A
ROA(3y)-2.64%
ROA(5y)-3.25%
ROE(3y)-1730.52%
ROE(5y)-1046.08%
ROIC(3y)N/A
ROIC(5y)N/A
EXPR Yearly ROA, ROE, ROICEXPR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 0 -1K -2K -3K -4K

1.3 Margins

  • Looking at the Profit Margin, with a value of 10.01%, EXPR belongs to the top of the industry, outperforming 92.97% of the companies in the same industry.
  • In the last couple of years the Profit Margin of EXPR has grown nicely.
  • EXPR has a Gross Margin of 22.40%. This is in the lower half of the industry: EXPR underperforms 76.56% of its industry peers.
  • In the last couple of years the Gross Margin of EXPR has remained more or less at the same level.
Industry RankSector Rank
OM N/A
PM (TTM) 10.01%
GM 22.4%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5Y78.26%
GM growth 3Y1.31%
GM growth 5Y-0.5%
EXPR Yearly Profit, Operating, Gross MarginsEXPR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

0

2. EXPR Health Analysis

2.1 Basic Checks

  • EXPR does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • EXPR has more shares outstanding than it did 1 year ago.
  • EXPR has a better debt/assets ratio than last year.
EXPR Yearly Shares OutstandingEXPR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 0 0 0 0 0
EXPR Yearly Total Debt VS Total AssetsEXPR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B

2.2 Solvency

  • Based on the Altman-Z score of 0.97, we must say that EXPR is in the distress zone and has some risk of bankruptcy.
  • EXPR has a worse Altman-Z score (0.97) than 69.53% of its industry peers.
  • EXPR has a Debt/Equity ratio of 1.83. This is a high value indicating a heavy dependency on external financing.
  • Looking at the Debt to Equity ratio, with a value of 1.83, EXPR is doing worse than 67.19% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.83
Debt/FCF N/A
Altman-Z 0.97
ROIC/WACCN/A
WACC15.82%
EXPR Yearly LT Debt VS Equity VS FCFEXPR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 200M -200M 400M 600M

2.3 Liquidity

  • A Current Ratio of 0.98 indicates that EXPR may have some problems paying its short term obligations.
  • Looking at the Current ratio, with a value of 0.98, EXPR is doing worse than 86.72% of the companies in the same industry.
  • EXPR has a Quick Ratio of 0.98. This is a bad value and indicates that EXPR is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 0.19, EXPR is doing worse than 85.94% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.98
Quick Ratio 0.19
EXPR Yearly Current Assets VS Current LiabilitesEXPR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M 500M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. EXPR Growth Analysis

3.1 Past

  • The earnings per share for EXPR have decreased strongly by -521.75% in the last year.
  • EXPR shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 76.94% yearly.
  • EXPR shows a decrease in Revenue. In the last year, the revenue decreased by -8.11%.
  • Measured over the past years, EXPR shows a decrease in Revenue. The Revenue has been decreasing by -2.89% on average per year.
EPS 1Y (TTM)-521.75%
EPS 3YN/A
EPS 5Y76.94%
EPS Q2Q%29.1%
Revenue 1Y (TTM)-8.11%
Revenue growth 3Y-2.63%
Revenue growth 5Y-2.89%
Sales Q2Q%4.6%

3.2 Future

  • EXPR is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 16.01% yearly.
  • Based on estimates for the next years, EXPR will show a small growth in Revenue. The Revenue will grow by 2.32% on average per year.
EPS Next Y-135.77%
EPS Next 2Y14.55%
EPS Next 3Y16.01%
EPS Next 5YN/A
Revenue Next Year-1.98%
Revenue Next 2Y2.16%
Revenue Next 3Y2.32%
Revenue Next 5YN/A

3.3 Evolution

  • Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
EXPR Yearly Revenue VS EstimatesEXPR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 500M 1B 1.5B 2B
EXPR Yearly EPS VS EstimatesEXPR Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 -20 -40 -60 -80 -100

More info and screens

Find the best growth stocksShow best growing peers

0

4. EXPR Valuation Analysis

4.1 Price/Earnings Ratio

  • EXPR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for EXPR. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
EXPR Price Earnings VS Forward Price EarningsEXPR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
EXPR Per share dataEXPR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 100 200 300 400

4.3 Compensation for Growth

  • A more expensive valuation may be justified as EXPR's earnings are expected to grow with 16.01% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y14.55%
EPS Next 3Y16.01%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. EXPR Dividend Analysis

5.1 Amount

  • EXPR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

EXPR Fundamentals: All Metrics, Ratios and Statistics

EXPRESS INC

NYSE:EXPR (3/6/2024, 8:04:00 PM)

2.29

+0.06 (+2.69%)

Chartmill FA Rating
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)11-30
Earnings (Next)N/A
Inst Owners0%
Inst Owner Change0%
Ins Owners197.99%
Ins Owner Change0%
Market Cap8.59M
Revenue(TTM)1.79B
Net Income(TTM)178.89M
Analysts82.86
Price Target20.4 (790.83%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)11.5%
Min EPS beat(2)3.19%
Max EPS beat(2)19.81%
EPS beat(4)3
Avg EPS beat(4)1.52%
Min EPS beat(4)-31.14%
Max EPS beat(4)19.81%
EPS beat(8)6
Avg EPS beat(8)57.46%
EPS beat(12)10
Avg EPS beat(12)110.69%
EPS beat(16)11
Avg EPS beat(16)59.58%
Revenue beat(2)0
Avg Revenue beat(2)-4.35%
Min Revenue beat(2)-5.54%
Max Revenue beat(2)-3.17%
Revenue beat(4)0
Avg Revenue beat(4)-4.56%
Min Revenue beat(4)-6.05%
Max Revenue beat(4)-3.17%
Revenue beat(8)1
Avg Revenue beat(8)-3.63%
Revenue beat(12)3
Avg Revenue beat(12)-2.74%
Revenue beat(16)3
Avg Revenue beat(16)-5.37%
PT rev (1m)21.21%
PT rev (3m)21.21%
EPS NQ rev (1m)-34.22%
EPS NQ rev (3m)-703.11%
EPS NY rev (1m)-7.14%
EPS NY rev (3m)-55.01%
Revenue NQ rev (1m)0.24%
Revenue NQ rev (3m)-4.96%
Revenue NY rev (1m)0.05%
Revenue NY rev (3m)-3.87%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0
P/FCF N/A
P/OCF N/A
P/B 0.06
P/tB 0.06
EV/EBITDA N/A
EPS(TTM)-49.74
EYN/A
EPS(NY)-15.54
Fwd EYN/A
FCF(TTM)-63.72
FCFYN/A
OCF(TTM)-51.35
OCFYN/A
SpS476.52
BVpS39.45
TBVpS39.45
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA 12.19%
ROE 120.91%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 10.01%
GM 22.4%
FCFM N/A
ROA(3y)-2.64%
ROA(5y)-3.25%
ROE(3y)-1730.52%
ROE(5y)-1046.08%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5Y78.26%
GM growth 3Y1.31%
GM growth 5Y-0.5%
F-Score4
Asset Turnover1.22
Health
Industry RankSector Rank
Debt/Equity 1.83
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 80.49%
Cap/Sales 2.6%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.98
Quick Ratio 0.19
Altman-Z 0.97
F-Score4
WACC15.82%
ROIC/WACCN/A
Cap/Depr(3y)50.21%
Cap/Depr(5y)50.38%
Cap/Sales(3y)1.93%
Cap/Sales(5y)2%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-521.75%
EPS 3YN/A
EPS 5Y76.94%
EPS Q2Q%29.1%
EPS Next Y-135.77%
EPS Next 2Y14.55%
EPS Next 3Y16.01%
EPS Next 5YN/A
Revenue 1Y (TTM)-8.11%
Revenue growth 3Y-2.63%
Revenue growth 5Y-2.89%
Sales Q2Q%4.6%
Revenue Next Year-1.98%
Revenue Next 2Y2.16%
Revenue Next 3Y2.32%
Revenue Next 5YN/A
EBIT growth 1Y-924.74%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-76.87%
EBIT Next 3Y36.9%
EBIT Next 5YN/A
FCF growth 1Y-1482.48%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-3156.62%
OCF growth 3YN/A
OCF growth 5YN/A

EXPRESS INC / EXPR Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for EXPRESS INC?

ChartMill assigns a fundamental rating of 2 / 10 to EXPR.


What is the valuation status of EXPRESS INC (EXPR) stock?

ChartMill assigns a valuation rating of 0 / 10 to EXPRESS INC (EXPR). This can be considered as Overvalued.


What is the profitability of EXPR stock?

EXPRESS INC (EXPR) has a profitability rating of 4 / 10.


How sustainable is the dividend of EXPRESS INC (EXPR) stock?

The dividend rating of EXPRESS INC (EXPR) is 0 / 10 and the dividend payout ratio is 0%.